Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) Stock Analysis & Winston Score

Laboratorios Farmaceuticos Rovi is a Spanish pharmaceutical company that makes and sells specialty medicines and generic drugs. Its main products include low-molecular-weight heparins (blood thinners), hormone therapies, and other prescription medicines sold mostly to hospitals and pharmacies across Europe. Rovi is also one of the few companies in the world with its own injectable drug manufacturing technology, called ISM, which can turn short-acting drugs into long-lasting injectable treatments. Rovi makes money by selling its own branded medicines and by manufacturing drugs under contract for other pharmaceutical companies. It operates mainly in Spain and other European markets, with contract manufacturing adding a meaningful global dimension through partnerships with large drugmakers like Moderna, for whom it filled COVID-19 vaccine doses. Its gross margin above 60% reflects the value of its proprietary products and manufacturing capabilities. The key growth driver is expanding its ISM injectable platform into new drugs, though losing or scaling back large contract manufacturing deals remains a real risk to revenue.